Devendra Kirti Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-07-2024
- Paid Up Capital ₹ 0.39 M
as on 03-07-2024
- Company Age 38 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 8.88 Cr
as on 03-07-2024
- Revenue 30.33%
(FY 2021)
- Profit 22.04%
(FY 2021)
- Ebitda 1.66%
(FY 2021)
- Net Worth -13.90%
(FY 2021)
- Total Assets -22.15%
(FY 2021)
About Devendra Kirti Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.39 M.
The company currently has active open charges totaling ₹8.88 Cr.
Abhay Chaudhari and Kushal Velaskar serve as directors at the Company.
- CIN/LLPIN
U99999MH1986PTC040395
- Company No.
040395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 1986
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Palghar, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Devendra Kirti Pharmachem Pvt. Ltd. offer?
Devendra Kirti Pharmachem Pvt. Ltd. offers a wide range of products and services, including Vitamin Powder API, Ferric Ammonium Citrate Powder API, Heptahydrate, Zinc Sulphate Heptahydrate, Fertilizers and Soil Additives, Micronutrient Fertilizers, Chemical Reagents & Catalysts, Ammonium Compound.
Who are the key members and board of directors at Devendra Kirti Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Chaudhari  | Director | 18-Mar-2011 | Current |
| Kushal Velaskar | Director | 16-Dec-2016 | Current |
Financial Performance of Devendra Kirti Pharmachem.
Devendra Kirti Pharmachem Pvt. Ltd., for the financial year ended 2021, experienced significant growth in revenue, with a 30.33% increase. The company also saw a substantial improvement in profitability, with a 22.04% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devendra Kirti Pharmachem?
In 2021, Devendra Kirti Pharmachem had a promoter holding of 94.87% and a public holding of 5.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunil Chemicals And Plastics Private LimitedActive 41 years 11 monthsAbhay Chaudhari is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Mar 2018 | ₹5.00 M | Open |
Others Creation Date: 28 Dec 2017 | ₹1.70 Cr | Open |
Others Creation Date: 30 Jun 2017 | ₹0.60 M | Open |
How Many Employees Work at Devendra Kirti Pharmachem?
Devendra Kirti Pharmachem has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devendra Kirti Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devendra Kirti Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
